These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Pratheeshkumar P; Son YO; Budhraja A; Wang X; Ding S; Wang L; Hitron A; Lee JC; Kim D; Divya SP; Chen G; Zhang Z; Luo J; Shi X PLoS One; 2012; 7(12):e52279. PubMed ID: 23300633 [TBL] [Abstract][Full Text] [Related]
7. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632 [TBL] [Abstract][Full Text] [Related]
8. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro. Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951 [TBL] [Abstract][Full Text] [Related]
9. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling. Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654 [TBL] [Abstract][Full Text] [Related]
10. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects. Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033 [TBL] [Abstract][Full Text] [Related]
11. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis. Chen L; Liu L; Ye L; Shen A; Chen Y; Sferra TJ; Peng J Oncol Rep; 2013 Sep; 30(3):1439-43. PubMed ID: 23820929 [TBL] [Abstract][Full Text] [Related]
12. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2. Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027 [TBL] [Abstract][Full Text] [Related]
13. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway. Chen J; Zhou Z; Yao Y; Dai J; Zhou D; Wang L; Zhang QQ J Cell Mol Med; 2018 Oct; 22(10):4760-4770. PubMed ID: 30010249 [TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978 [TBL] [Abstract][Full Text] [Related]
15. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway. Niu G; Sun L; Pei Y; Wang D Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844 [TBL] [Abstract][Full Text] [Related]
16. A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization. Palmer GM; Tiran Z; Zhou Z; Capozzi ME; Park W; Coletta C; Pyriochou A; Kliger Y; Levy O; Borukhov I; Dewhirst MW; Rotman G; Penn JS; Papapetropoulos A Br J Pharmacol; 2012 Mar; 165(6):1891-1903. PubMed ID: 21943108 [TBL] [Abstract][Full Text] [Related]
17. The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4. Su M; Huang J; Liu S; Xiao Y; Qin X; Liu J; Pi C; Luo T; Li J; Chen X; Luo Z Sci Rep; 2016 Jun; 6():28139. PubMed ID: 27338725 [TBL] [Abstract][Full Text] [Related]
18. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects. Gao W; Jin K; Lan H; Han N; Cao F; Teng L Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543 [TBL] [Abstract][Full Text] [Related]
19. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway. Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884 [TBL] [Abstract][Full Text] [Related]
20. α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway. Saraswati S; Kumar S; Alhaider AA Mol Cancer; 2013 Nov; 12():147. PubMed ID: 24261856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]